Insights from daratumumab use in highly sensitized pediatric heart transplant candidates and recipients: A single-center institutional experience and outcomes

By afschroeder • August 19, 2025

Husain M, Butler C, Fan AM, Halnon NJ, Reardon LC, Alejos JC. Insights from daratumumab use in highly sensitized pediatric heart transplant candidates and recipients: A single-center institutional experience and outcomes. JHLT Open. 2025 Jul 17;10:100346. doi: 10.1016/j.jhlto.2025.100346. PMID: 40822087; PMCID: PMC12354783.

Tags: allosensitization, Cardiology/Epi, complex congenital heart disease, daratumumab, desensitization, Pediatric heart transplant, Publications

InChagas: Feasibility Study of a Tele-Education Strategy to Promote Early Identification and Care of People Living with Chagas Cardiomyopathy in an Endemic Community in Argentina

Gulayin PE, Gimenez C, Chirino D, Nascimento B, Salvá L, Cavallo AS, Gutierrez L, Blanco L, Flores LPC, Espina E, Shakil SS, Vervoort D, Davis[...]

Authors’ Perspective-Summary of the International Society for Heart and Lung Transplantation (ISHLT) Consensus Conference on Graft Dysfunction within the First 72 hours after Heart Transplantation: A 10-year Update

Kobashigawa J, Zuckermann A, Potena L, Ardehali A, Berman M, Chang PP, Esmailian F, Farr M, Hall S, Hsich E, Khush K, Kittleson M, Leprince[...]

Protocol optimization for 18F-flurpiridaz positron emission tomography myocardial perfusion imaging to enhance clinical workflow

Ali FZ, Packard RRS. Protocol optimization for 18F-flurpiridaz positron emission tomography myocardial perfusion imaging to enhance clinical workflow. J Nucl Cardiol. 2026 Apr;58:102674. doi: 10.1016/j.nuclcard.2026.102674. PMID:[...]